Azuma M - Search Results

1

Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.

Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M. Mogi S, et al. Among authors: azuma m. Clin Cancer Res. 1998 Mar;4(3):713-20. Clin Cancer Res. 1998. PMID: 9533541

2

Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells.

Mogi S, Sakurai J, Kohsaka T, Enomoto S, Yagita H, Okumura K, Azuma M. Mogi S, et al. Among authors: azuma m. Immunology. 2000 Dec;101(4):541-7. doi: 10.1046/j.1365-2567.2000.t01-1-00138.x. Immunology. 2000. PMID: 11122458 Free PMC article.

3

Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.

Ebata T, Mogi S, Hata Y, Fujimoto JI, Yagita H, Okumura K, Azuma M. Ebata T, et al. Among authors: azuma m. Eur J Immunol. 2001 May;31(5):1410-6. doi: 10.1002/1521-4141(200105)31:5<1410::AID-IMMU1410>3.0.CO;2-H. Eur J Immunol. 2001. PMID: 11465097 Free article.

4

B70 antigen is a second ligand for CTLA-4 and CD28.

Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. Azuma M, et al. Nature. 1993 Nov 4;366(6450):76-9. doi: 10.1038/366076a0. Nature. 1993. PMID: 7694153

5

B7-1 synergizes with interleukin-12 in interleukin-2 receptor alpha expression by mouse T helper 1 clones.

Igarashi O, Yanagida T, Azuma M, Okumura K, Nariuchi H. Igarashi O, et al. Among authors: azuma m. Eur J Immunol. 1996 Feb;26(2):300-6. doi: 10.1002/eji.1830260205. Eur J Immunol. 1996. PMID: 8617295

6

Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.

Bashuda H, Seino K, Kano M, Sato K, Azuma M, Yagita H, Okumura K. Bashuda H, et al. Among authors: azuma m. Transplant Proc. 1996 Apr;28(2):1039-41. Transplant Proc. 1996. PMID: 8623220 No abstract available.

7

The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.

Nuriya S, Yagita H, Okumura K, Azuma M. Nuriya S, et al. Among authors: azuma m. Int Immunol. 1996 Jun;8(6):917-26. doi: 10.1093/intimm/8.6.917. Int Immunol. 1996. PMID: 8671681

8

Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.

Kaneko H, Saito K, Hashimoto H, Yagita H, Okumura K, Azuma M. Kaneko H, et al. Among authors: azuma m. Clin Exp Immunol. 1996 Nov;106(2):218-29. doi: 10.1046/j.1365-2249.1996.d01-849.x. Clin Exp Immunol. 1996. PMID: 8918566 Free PMC article.

9

Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease.

Saito K, Yagita H, Hashimoto H, Okumura K, Azuma M. Saito K, et al. Among authors: azuma m. Eur J Immunol. 1996 Dec;26(12):3098-106. doi: 10.1002/eji.1830261241. Eur J Immunol. 1996. PMID: 8977310

10

Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells.

Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K, Azuma M. Nakajima A, et al. Among authors: azuma m. Int Immunol. 1997 May;9(5):637-44. doi: 10.1093/intimm/9.5.637. Int Immunol. 1997. PMID: 9184909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,389 results

Search Page

Filters